Zimmer Partners, LP Astrazeneca PLC Transaction History

Zimmer Partners, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $4.94 Million - $5.97 Million	-73,900 Reduced 26.88%	201,000 $15.7 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $3.46 Million - $3.94 Million	56,700 Added 25.99%	274,900 $18.6 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $10.7 Million - $12 Million	173,400 Added 387.05%	218,200 $14.7 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $3.13 Million - $3.4 Million	44,800 New	44,800 $3.21 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Zimmer Partners, LP with notifications on news.